Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 4
Submit an article Journal homepage
29
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Adjusted Conditioning for Allogeneic Transplantation in a Single Center Setting: Mixed Chimerism Heralds Relapse

Gunnar Juliusson Department of Hematology and Blood Bank Service, University Hospital Linköping, Institution for Biomedicine and Surgery, Faculty of Health Sciences, University of Linköping, and Department of Forensic Medicine, SE-58185 Linköping, Sweden
,
Karin Karlsson Department of Hematology and Blood Bank Service, University Hospital Linköping, Institution for Biomedicine and Surgery, Faculty of Health Sciences, University of Linköping, and Department of Forensic Medicine, SE-58185 Linköping, Sweden
,
Claes Malm Department of Hematology and Blood Bank Service, University Hospital Linköping, Institution for Biomedicine and Surgery, Faculty of Health Sciences, University of Linköping, and Department of Forensic Medicine, SE-58185 Linköping, Sweden
,
Ulla Frödin Department of Hematology and Blood Bank Service, University Hospital Linköping, Institution for Biomedicine and Surgery, Faculty of Health Sciences, University of Linköping, and Department of Forensic Medicine, SE-58185 Linköping, Sweden
,
Agneta Seger Mollén Department of Hematology and Blood Bank Service, University Hospital Linköping, Institution for Biomedicine and Surgery, Faculty of Health Sciences, University of Linköping, and Department of Forensic Medicine, SE-58185 Linköping, Sweden
,
Gerd Bäckström Department of Hematology and Blood Bank Service, University Hospital Linköping, Institution for Biomedicine and Surgery, Faculty of Health Sciences, University of Linköping, and Department of Forensic Medicine, SE-58185 Linköping, Sweden
&
Peter Söderkvist Department of Hematology and Blood Bank Service, University Hospital Linköping, Institution for Biomedicine and Surgery, Faculty of Health Sciences, University of Linköping, and Department of Forensic Medicine, SE-58185 Linköping, Sweden
 show all
Pages 669-679 | Published online: 01 Jul 2009

  • Barren. J. and Childs. R. (2000) "Non-myeloablative stem cell transplants". Br. J. Haematol. 111(1). 6-17.
  • Thomas. E.D., Burkner, C.D., Rudolph, R.H., Feier, A., Storb, R., Neiman, P.E., Bryant, L.I., Chard, R.L., Clift, R.A., Epstein, R.B., Fialkow, P.J., Funk, D.D., Giblett, E.R., Lerner, K.G., Reynolds, F.A. and Slichter, S (1971) "Allogeneic marrow grafting for hematologic malignancy using HL-A matched donor-recipient sibling pairs". Blood 38(3), 267-287.
  • Santos, G.W., Sensenbrenner, L.L., Burke, P.J., Colvin, M., Owens, Jr., A.H., Bias, W.B. and Slavin, R.E. (1971) "Marrow transplantation in man following cyclophosphamide". Transplant. Proc. 3(1), 400-404.
  • Tuischka, P.J., Copelan, E.A. and Klein, J.P. (1987) "Bone marrow transplantation for leukemia following a new husulfan and cyclophosphamide regimen". Blood 70(5), 1382-1388.
  • Demirer, T., Petersen, F.B., Appelbaum, F.R., Barnett, T.A., Sanders, J., Deep, H.J., Storb, R., Doney, K., Bensinger, W.I., Shannon-Durey, K., et al. (1995) "Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a phase I/II trial". Int. J. Radiat. Oncol. Biol. Phys. 32(4), 1103-1109.
  • Kroger, N., Zabelina, T., Sonnenberg, S., Kruger, W., Renges, H., Stute, N., Finkenstein, F., Mayer, U., Holstein, K., Fiedler, W., Colberg, H., Sonnen, R., Kuse, R., Braumann, D., Metzner, B., del VaIIe, F., Erttmann, R., Kabisch, H. and Zander, A.R. (2000) "Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning gor stem cell transplantation in patients with acute myeloid leukemia". Bone Marrow Transplant. 26(1), 711-716.
  • Spitzer, T.R., Cottler-Fox, M., Torrisi, J., Cahill, R., Greenspan, A., Lynch, M. and Deeg, H.J. (1989) "Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation". Bone Marrow Transplant. 4(5), 559-565.
  • Schaltenberg, A., Schaap, N., Preijers, F., van der Maazen, R. and de Wine, T. (2000) "Outcome of T cell-depleted transplantation after conditioning with an intensified regimen in patients aged 50 years or more is comparable with that in younger patients". Bone Marrow Transplant. 26(1), 17-22.
  • Bjorkstrand, B. (2001) "Europeun Group for blood and marrow transplantation registry studies in multiple myeloma". Semin. Hematol. 38(3), 219-225.
  • Moreau, P., Facon, T., Altai, M., Hulin, C., Michallet, M., Maloisel, F., Sotto, JJ., Guilhot, E., Marit, G., Doyen, C., Jaubert, J., Fuzihet, J.G., Francois, S., Benboubker, L., Monconduit, M., Voillat, L., Macro, M., Berthou, C., Dorvaux, V., Pignon, B., et al. (2002) "Comparison of 200mg/m(2) melphalan and 8 Gy total body irradiation plus 140mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial". Blood 99(3), 731-735.
  • Storb, R., Yu, C., Wagner, J.L., Deeg, H.J., Nash, R.A., Kiem, H.P., Leisenring, W. and Shulman, H. (1997) "Stable mixed hematopoietic chimerism in DLA-idenlical littermate dogs given suhlethal total body irradiation before and pharmacological immunosuppression after marrow transplantation". Blood 89(8), 3048-3054.
  • Georges, G.E., Storb, R. Thompson, J.D., Yu, C. Gooley, T., Bruno, B. and Nash, R.A. (2000) "Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation". Blood 95(10), 3262-3269.
  • Childs, R., Chemof, A.,Contentin, N., Bahceci, E., Schrump, D., Leilman, S., Read, E.J., Tisdale, J., Dunbar. C., Linehan, W.M., Young, N.S. and Barren, A.J. (2000) "Regression of melastalic renal-cell carcinoma after nonmyeloablative allogeneic peripheral- blood stem-cell transplantation". N. Engl. J. Med. 343(11), 750 758.
  • Estey, E.H. (2000) "How I treat older patients with AML". Blood 96(5), 1670-1673.
  • Juliusson, G., Karlsson, K. and Malm, C. (2002) "More potentgraltversus-mycloma effect than graft-versus-renal cell cancer effecl". Leuk. Lymphoma 43(D). In press.
  • Lee, S.J., Fairclough, D., Parsons, S.K., Soifler, R.J., Fisher, D.C., Schlossmnn, R.L., Antin, J.H. and Weeks, J.C. (2001) "Recovery after stem-cell transplantation for hematologic diseases". J. Clin. Oncol. 19(1), 242-252.
  • Wijermans, P.W., Gerrits, W.B. and Haak, H.L. (1993) "Severe immunodeficiency in patients treated with fludarabine monophosphate". Eur. J. Haematol. 50(5), 292-296.
  • Johnson, S. Smith, A.G., Loffler, H., Osby, E., Juliusson, G., Enunerich, B., WyId, P.J. and Hiddemann, W. (1996) "Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) tor treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL". Lancet 347(9013), 1432-1438.
  • Boogaerts, M.A., Van Hoof, A., Catovsky, D., Kovaes, M., Montillo, M., Zinzani, P.L., Biuet, J.L., Feretnans, W., Marcus, R., Bosch, F. Verhoef, G. and Klein, M. (2000) "Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia". J. Clin. Oncol. 19(22), 4252-4258.
  • Gurney, H. (1996) "Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative". J Clin Oncol. 14(9), 2590-2611.
  • Bleyer, W.A. (1998) "A flat dose for all adult [sic) patients", J. Clin. Oncol. 16(11), 3715.
  • Ratain, M.J. (1998) "Body-surface area as a basis for dosing of anticancer agents: science, myth, or habit?", J. Clin. Oncol. 16(7), 2297-2298.
  • Bellosillo, B., Villamor, N., Colomer, D., Pons, G., Montserrat, E. and Gil, J. (1999) "In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-ceII chronic lymphocytic leukemia". Blood 94(8), 2836-2843.
  • O'Brien, S.M., Kamarjian, H.M., Cortes, J., Beran, M., Koller, C.A., Giles, F.J., Lerner, S. and Keating, M. (2001) "Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia". J. Clin. Oncol. 19(5), 1414-1420.
  • Bapley, Jr., C.M., Devita, Jr., V.T., Berard, C.W. and Canellos, G.P. (1972) "Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide. vincristine, and prednisone". Ann. lntern. MedJ. 76(2), 227-234.
  • Plunkell, W., Liliemark, J.O., Adams, T.M., Nowak, B., Estey, E., Kantarjian, H. and Keating, M.J. (1987) "Saturation of 1-beia-D-arabinofuranosyleytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosyleytosine therapy". Cancer Res. 47(11), 3005-3011.
  • Gandhi, V., Estey, K., Keating, M.J. and Plunkeit, W. (1993) "Fludarabine potentiates metabolism of cytarahine in patients with acute myelogenous leukemia during therapy". J. Clin. Oncol 11(1), 116-124.
  • Estey, E., Plunkett, W., Gandhi, V. Rios, M.B., Kamarjian, H. and Keating, M.J. (1993) "Fludarabine and arabinosyleytosine therapy of refractory and relapsed acute myclogenous leukemia". Leuk. Lymphoma 9(4-5), 343-350.
  • Helenglass, G., Powles, R.L., McElwain, T.J., Lakhani, A., Milan, S., Gore, M., Nandi, A., Zuiable, A., Perren, T., Foregeson, G., et al. (1988) "Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission". Bone Marrow Transplant. 3(1), 21-29.
  • Powles, R., Singhal, S., Treleavan, J., Kulkarni, S., Horton, C. and Mehta, J. (1998) "Identification of patients who may benefit from prophylactic immunotherapy after hone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation". Blood 91(9), 3481-3486.
  • McElwain, T.J. and Powles, R.L. (1983) "High-dose intravenous melphalan for plasma-cell leukaemia and myeloma". Lancet 2(8354), 822-824.
  • Hale, G., Zhang, M.J., Bunjes, D., Prentice, H.G., Spence, D., Horowitz, M.M., Barrett, A.J. and Waldmann, H. (1998) "Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection". Blood 92(12), 4581-4590.
  • Bowen, A.L., Zomas, A., Emmett, E., Matutes, E., Dyer, M.J. and Catovsky, D. (1997) "Subcutaneous CAMPATH-1H in fludarabine-resisiant/relapsed chronic lymphocytic and B-prolymphocytic leukaemia". Br. J. Haematol. 96(3), 617-619.
  • Lundin, J., Kimby, E., Bjorkholm, M., Celsing, K., Hale, G., Hjalmar, V., Merup, M., Peirescu, A., Tullgren, O., Waldmann, H., MeIlstedt, H. and Osterborg, A. (2001) "Phase II study of subcutaneous alemtuzumab (Campath-IH) therapy in patients with previously untreated chronic lymphocytic leukemia". Blood 98(11), 772a, abstract#3215.
  • Schnitzer, T.J., Yocum, D.E., Michalska, M., Balius, R., Snider, M.E., Hays. A., Thurmond, L.M. and Johnston, J.M. (1997) "Subcutaneous administration of CAMFATH-IH: clinical and biological outcomes". J. Rheumatol. 24(6), 1031-1036.
  • Anderson, P.M., Ramsay, N.K., Shu, X.O., Rydbolm, N., Rogosheske, J., Nickkm, R., Weisdorf, D.J. and Skubitz, K.M.(1998) "Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation". Bone Marrow Transplant. 22(4), 339-344.
  • Thiede, C., Bornhauser, M., Oelschlagel, U., Brendel, C., Leo, R., Daxberger, H., Mohr, B., Florek, M., Kroschinsky, F., Geissler, G., Naumann, R., Ritter, M., Prange-Krex, G., Lion, T., Neubauer, A. and Ehninger, G. (2001) "Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers". Leukemia 15(2), 293-302.
  • Dazzi, F., Szydio, R.M., Craddock, C., Cross, N.C., Kaeda, J., Cruise, A., Olavarria, E., van Rhee, F., Kanfer, E., Appertey, J.E. and Goldman, J.M. (2000) "Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia". Blood 95(1), 67-71.
  • Frodin, U. and Jufiusson, G. (2002) "Campath by subcutaneous injection instead of ATG as part of reduced intensity conditioning for allogeneic transplantation from a nurse's point of view". Bone Marrow Transplant. 29(Suppl. 2), S269.
  • McSweeney, P.A., Niederwieser, D., Shizuru, J.A., Sandmaier, B.M., Molina, A.J., Maloney, D.G., Chauncey, T.R., Gooley, T.A., Hegenbart, U., Nash, R.A., Radich, J., Wagner, J.L., Minor, S., Appelbaum, F.R., Bensiager, W.I., Bryant, E., Flowers, M.E., Georges, G.E., Grumet, F.C., Kiem, H.P., et al. (2001) "Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effetts". Blood 97(11), 3390-3400.
  • Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G., Kirschbaum, M., Ackerstein, A., Samuel, S., Amar, A., Barutbar, C., Ren-Tal, O., Eldor, A. and Or, R. (1998) "Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases". Blood 91(3), 756-763.
  • Mattsson, U., Uzunel, M., Brune, M., Hentschke, P., Barkholt, L., Stierner, U., Aschan, J. and Ringden, O. (2001) "Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation". Br, J. Haematol. 115(4), 935-944.
  • Alyea, E., Weller, E., Schlossman, R., Canning, C., Webb, I., Doss, D., Mauch, P. Marcus, K., Fisher, D., Freeman, A., Parikh, B., Gribben, J., Soiffer, R., Ritz. J. and Anderson, K. (2001) "T-cell-depleled allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect". Blood 98(4), 934-939.
  • Nakamura, R., Bahceci, E., Read, E.J., Leitman, S.F., Carter, C.S., Childs, R., Dunbar, C.E., Gress, R., Allemus, R., Young, N.S. and Barren, A.J. (2001) "Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-back". Br. J. Haematol. 115(1), 95-104
  • Chakrabarti, S., Mackinnon, S., Chopra, R., Koltaridis, P.D., Peggs, K., O'Gorman, P., Chakraverty, R., Marshall, T., O'sman, H., Mahendra, P., Craddoek, C., Waldmann, H., Hale, G., Fegan, C.D., Yong, K., Goldstone, A.H., Linch, D.C. and Milligan, D.W. (2002) "High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-IH in delaying immune reconstitution". Blood 99(12), 4357-4363.
  • Stotek, J., Dawson, M.A., Storer, B., Stevens-Ayers, T., Maloney, D.G., Marr, K.A., Witherspoun, R.P., Bensinger, W., Flowers, M.K., Martin, P. Storb, R., Appelbaum, F.R. and Boeckh, M. (2001) "Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation". Blood 97(11), 3380-3389.
  • Morecki, S., Gelfand, Y., Nagler, A., Or, R., Naparstek, E., Varadi, G., Engelhard, D., Akerstein, A. and Slavin, S. (2001) "Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen". Bone Marrow Transplant. 28(3), 243-249.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.